Aytu BioPharma (AYTU) Short Interest Ratio & Short Volume → Trump’s last act as President (From Porter & Company) (Ad) Free AYTU Stock Alerts $2.89 +0.08 (+2.84%) (As of 05/1/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Aytu BioPharma Short Interest DataCurrent Short Volume402,500 sharesPrevious Short Volume360,900 sharesChange Vs. Previous Month+11.53%Dollar Volume Sold Short$1.07 millionShort Interest Ratio / Days to Cover19.8Last Record DateApril 15, 2024Outstanding Shares5,570,000 sharesFloat Size5,360,000 sharesShort Percent of Float7.51%Today's Trading Volume7,935 sharesAverage Trading Volume18,358 sharesToday's Volume Vs. Average43% Short Selling Aytu BioPharma ? Sign up to receive the latest short interest report for Aytu BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAYTU Short Interest Over TimeAYTU Days to Cover Over TimeAYTU Percentage of Float Shorted Over Time Ad MillPub😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.Click here to save your seat and join the next LIVE workshop! Aytu BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024402,500 shares $1.07 million +11.5%7.5%19.8 $2.67 3/31/2024360,900 shares $1.10 million -0.2%6.7%18 $3.04 3/15/2024361,600 shares $1.04 million +3.5%6.8%16.9 $2.87 2/29/2024349,500 shares $1.01 million +4.4%6.5%14.8 $2.89 2/15/2024334,900 shares $1.04 million +6.3%6.3%14.6 $3.12 1/31/2024315,100 shares $860,223.00 -9.6%5.9%11 $2.73 Get the Latest News and Ratings for AYTU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aytu BioPharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024348,500 shares $892,160.00 -7.4%6.5%9.1 $2.56 12/31/2023376,300 shares $1.07 million -8.2%7.0%7.9 $2.84 12/15/2023409,800 shares $1.20 million -11.7%7.7%2.5 $2.93 11/30/2023464,000 shares $1.06 million -23.1%8.7%2.8 $2.29 11/15/2023603,000 shares $1.38 million -4.7%11.3%3.7 $2.29 10/31/2023632,800 shares $1.73 million -14.9%12.1%4 $2.73 10/15/2023743,200 shares $2.22 million +112.6%14.2%4.8 $2.99 9/30/2023349,600 shares $943,920.00 +5.8%9.8%2.4 $2.70 9/15/2023330,300 shares $535,086.00 -6.4%9.3%11.2 $1.62 8/31/2023352,800 shares $599,760.00 +12.0%9.9%8.9 $1.70 8/15/2023314,900 shares $588,863.00 -1.7%8.8%6.8 $1.87 7/31/2023320,200 shares $579,562.00 -6.2%8.9%5.6 $1.81 7/15/2023341,500 shares $638,605.00 -8.8%9.5%4.1 $1.87 6/30/2023374,600 shares $599,360.00 -39.3%10.5%4.4 $1.60 6/15/2023616,700 shares $1.14 million +3.3%17.2%7.4 $1.85 5/31/2023596,800 shares $996,656.00 -0.1%16.6%7.4 $1.67 5/15/2023597,300 shares $1.07 million +23.6%16.6%7.2 $1.79 4/30/2023483,200 shares $1.14 million -9.6%14.3%6.2 $2.35 4/15/2023534,300 shares $1.36 million +4.1%15.8%9.8 $2.55 3/31/2023513,200 shares $1.15 million +3.1%15.2%7.9 $2.24 3/15/2023497,600 shares $1.17 million +0.8%14.7%6.2 $2.35 2/28/2023493,900 shares $1.31 million +12.3%15.3%6.4 $2.66 2/15/2023440,000 shares $1.31 million +8.7%13.7%5.7 $2.98 1/31/2023404,700 shares $1.34 million +16.9%12.5%5.3 $3.30 1/15/2023346,300 shares $1.20 million +99.3%10.8%4.8 $3.47 12/30/2022173,800 shares $32,848.20 -93.9%N/A2.8 $0.19 12/15/20222,830,000 shares $602,507.00 -6.3%N/A2.6 $0.21 11/30/20223,020,000 shares $619,402.00 +24.8%N/A3 $0.21 11/15/20222,420,000 shares $473,110.00 +36.0%N/A2.3 $0.20 10/31/20221,780,000 shares $291,920.00 No ChangeN/A1.3 $0.16 10/15/20221,780,000 shares $295,658.00 +17.9%N/A1.3 $0.17 9/30/20221,510,000 shares $279,350.00 +42.5%N/A1.1 $0.19 9/15/20221,060,000 shares $231,080.00 -8.6%N/A0.8 $0.22 8/31/20221,160,000 shares $258,100.00 -22.2%N/A1 $0.22Trump’s last act as President (Ad)You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. AYTU Short Interest - Frequently Asked Questions What is Aytu BioPharma's current short interest? Short interest is the volume of Aytu BioPharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 402,500 shares of AYTU short. 7.51% of Aytu BioPharma's shares are currently sold short. Learn More on Aytu BioPharma's current short interest. What is a good short interest ratio for Aytu BioPharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AYTU shares currently have a short interest ratio of 20.0. Learn More on Aytu BioPharma's short interest ratio. Which institutional investors are shorting Aytu BioPharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aytu BioPharma: Concourse Financial Group Securities Inc., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aytu BioPharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.51% of Aytu BioPharma's floating shares are currently sold short. Is Aytu BioPharma's short interest increasing or decreasing? Aytu BioPharma saw a increase in short interest in April. As of April 15th, there was short interest totaling 402,500 shares, an increase of 11.5% from the previous total of 360,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aytu BioPharma's float size? Aytu BioPharma currently has issued a total of 5,570,000 shares. Some of Aytu BioPharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aytu BioPharma currently has a public float of 5,360,000 shares. How does Aytu BioPharma's short interest compare to its competitors? 7.51% of Aytu BioPharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aytu BioPharma: Vaxxinity, Inc. (9.31%), FSD Pharma Inc. (1.11%), Cocrystal Pharma, Inc. (0.02%), Tonix Pharmaceuticals Holding Corp. (1.76%), NeuroBo Pharmaceuticals, Inc. (2.63%), VBI Vaccines Inc. (2.65%), Minerva Neurosciences, Inc. (0.56%), Pieris Pharmaceuticals, Inc. (0.03%), Edesa Biotech, Inc. (0.65%), Orgenesis Inc. (1.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Aytu BioPharma stock? Short selling AYTU is an investing strategy that aims to generate trading profit from Aytu BioPharma as its price is falling. AYTU shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aytu BioPharma? A short squeeze for Aytu BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AYTU, which in turn drives the price of the stock up even further. How often is Aytu BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AYTU, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VAXX Short Interest Data HUGE Short Interest Data COCP Short Interest Data TNXP Short Interest Data NRBO Short Interest Data VBIV Short Interest Data NERV Short Interest Data PIRS Short Interest Data EDSA Short Interest Data ORGS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AYTU) was last updated on 5/2/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing